Fatty Liver Disease Cirrhosis Non-Alcoholic Fatty Liver Disease Liver Cirrhosis Alcoholic Liver Disease Nonalcoholic Fatty Liver Disease Fibrosis Nonalcoholic Steatohepatitis (NASH) Primary Biliary Cholangitis Metabolic Dysfunction-Associated Steatohepatitis
The analysis links the surge to shifting heavy-drinker profiles, including increased shares of women, middle-aged adults, low-income individuals, people with metabolic syndrome